perillyl alcohol has been researched along with Leukemia, Myeloid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, SS; Filiault, D; Gould, M; Perman, S; Ren, Z; Yang, X; Zhong, L | 1 |
| Barba-Barajas, M; Bravo Cuellar, A; Del Toro-Arreola, S; Delgado-Rizo, V; Domínguez-Rodríguez, JR; Gómez-Contreras, PC; Hernández-Flores, G; Lerma-Díaz, JM; Ortiz-Lazareno, PC | 1 |
| Clark, SS; Jenkins, G; Perman, SM; Sahin, MB | 1 |
3 other study(ies) available for perillyl alcohol and Leukemia, Myeloid
| Article | Year |
|---|---|
Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Transformed; Fusion Proteins, bcr-abl; Humans; Leukemia, Myeloid; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Monoterpenes; Oncogene Protein p21(ras); Perilla; Protein Prenylation; Proto-Oncogene Proteins c-raf; Signal Transduction; Tumor Cells, Cultured | 2003 |
In vitro induction of apoptosis in U937 cells by perillyl alcohol with sensitization by pentoxifylline: increased BCL-2 and BAX protein expression.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Biomarkers, Tumor; Blotting, Western; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Leukemia, Myeloid; Membrane Potential, Mitochondrial; Monoterpenes; Pentoxifylline; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; U937 Cells | 2006 |
Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Transformed; COS Cells; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; G1 Phase; Leukemia, Myeloid; Monoterpenes; Radiation Tolerance; Resting Phase, Cell Cycle; Structure-Activity Relationship; Terpenes | 1999 |